Skip to content

Clinical trials

Completed Leukemia, Myelogenous, Chronic, BCR-ABL Positive trials in Poland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Myelogenous, Chronic, BCR-ABL Positive Status: Completed Country / region: Poland Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20052
20061
20073
20083
20091
20101
20121
20133
20141
20151
20181
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed19

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals9
Pfizer3
Bristol-Myers Squibb2
Teva Branded Pharmaceutical Products R&D, Inc.2
European Society for Blood and Marrow Transplantation1
Takeda1
Wyeth is now a wholly owned subsidiary of Pfizer1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myelogenous, Chronic, BCR-ABL Positive19
Leukemia5
Leukemia, Myeloid4
Bone Marrow Diseases3
Hematologic Diseases3
Bronchiolitis Obliterans Syndrome2
Neoplasms by Histologic Type2
Precursor Cell Lymphoblastic Leukemia-Lymphoma2
Blast Crisis1
Breast Neoplasms1

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.